Abstract
Hereditary thrombophilias result in a hypercoagulable state that predisposes to the development of venous thromboembolism (VTE). However, VTE is a multifactorial disease and acquired risk factors occur commonly, such as immobility associated with trauma, surgery or hospitalisation due to medical illnesses, malignancy, pregnancy, hormone use and ageing (Lijfering et al. 2010; Goldhaber 2010; Barco et al. 2013; Martinelli et al. 2014). Furthermore, a family history of VTE, in first-degree relatives, is associated with an increase in VTE risk, even if the known hereditary thrombophilias are not detected (Bezemer et al. 2009; Sorensen et al. 2011). In most cases, decisions about VTE management are not altered by a diagnosis of hereditary thrombophilia. Consequently, the role of thrombophilia testing in clinical practice remains controversial, despite our increasing understanding of the pathophysiology involved.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barco S, Nijkeuter M, Middeldorp S. Pregnancy and venous thromboembolism. Semin Thromb Hemost. 2013;39:549–58.
Bezemer ID, van der Meer FJ, Eikenboom JC, Rosendaal FR, Doggen CJ. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med. 2009;169:610–5.
Brouwer JL, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The pathogenesis of venous thromboembolism: evidence for multiple interrelated causes. Ann Intern Med. 2006;145:807–15.
Bucur SZ, Levy JH, Despotis GJ, Spiess BD, Hillyer CD. Uses of antithrombin III concentrate in congenital and acquired deficiency states. Transfusion. 1998;38:481–98.
de Moerloose P, Casini A, Neerman-Arbez M. Congenital fibrinogen disorders: an update. Semin Thromb Hemost. 2013;39:585–95.
De Stefano V, Rossi E. Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups. Thromb Haemost. 2013;110:697–705.
Dentali F, et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost. 2012;38:535–48.
Favaloro EJ, Lippi G. Laboratory testing in the era of direct or non-vitamin K antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors. Semin Thromb Hemost. 2015;41:208–27.
Favaloro EJ, McDonald D. Futility of testing for factor V Leiden. Blood Transfus. 2012;10:260–3.
Favaloro EJ, Mohammed S, Pati N, Ho MY, McDonald D. A clinical audit of congenital thrombophilia investigation in tertiary practice. Pathology. 2011;43:266–72.
Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost. 2009;102:360–70.
Goldhaber SZ. Risk factors for venous thromboembolism. J Am Coll Cardiol. 2010;56:1–7.
Hirsh J, et al. Parenteral anticoagulants: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:141S–59.
Lensen RP, Bertina RM, de Ronde H, Vandenbroucke JP, Rosendaal FR. Venous thrombotic risk in family members of unselected individuals with factor V Leiden. Thromb Haemost. 2000;83:817–21.
Lijfering WM, et al. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood. 2009;113:5314–22.
Lijfering WM, Rosendaal FR, Cannegieter SC. Risk factors for venous thrombosis – current understanding from an epidemiological point of view. Br J Haematol. 2010;149:824–33.
Makelburg AB, et al. Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study. Haematologica. 2010;95:1030–3.
Martinelli I, De Stefano V, Mannucci PM. Inherited risk factors for venous thromboembolism. Nat Rev Cardiol. 2014;11:140–56.
Ranucci M, et al. Different patterns of heparin resistance: therapeutic implications. Perfusion. 2002;17:199–204.
Simone B, et al. Risk of venous thromboembolism associated with single and combined effects of factor V Leiden, prothrombin 20210A and methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol. 2013;28:621–47.
Sorensen HT, et al. Familial risk of venous thromboembolism: a nationwide cohort study. J Thromb Haemost. 2011;9:320–4.
Vossen CY, et al. Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost. 2004;2:1526–32.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Curnow, J., Pasalic, L., Favaloro, E.J. (2016). Hereditary Thrombophilias: Pathophysiology, Timing of Testing and Familial Testing. In: Abutalib, S., Connors, J., Ragni, M. (eds) Nonmalignant Hematology. Springer, Cham. https://doi.org/10.1007/978-3-319-30352-9_41
Download citation
DOI: https://doi.org/10.1007/978-3-319-30352-9_41
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-30350-5
Online ISBN: 978-3-319-30352-9
eBook Packages: MedicineMedicine (R0)